Busy But Not Profitable
in Healthcare Providers

The short answer

Full panels and thin margins is a contract selection and pricing problem wearing an operations costume. For healthcare providers, this shows up in a particular place. The numbers that carry the answer are cost per episode and payer mix, and the complication specific to this industry is that downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it. The general version of this problem and the one you are actually in have different first moves.

When a provider group is at capacity and still not making money, the instinct is to look for waste inside the practice. Usually there is some, and removing it will not fix this, because the cause is upstream: the attributed lives accepted under value-based contracts are not priced against the cost per episode they actually generate.

The pattern is consistent. A few payer mixes or panel segments earn well. A long tail of attributed lives earns nothing but keeps every provider occupied, so the group feels busy and the contribution margin disagrees. Because the tail fills the available panel size, the profitable contracts cannot expand — the constraint is not demand, it is that the constraint is already full of the wrong lives.

The fix is a selection rule, not a productivity programme. Once contribution per provider can be ranked by contract and episode type, most of the decision makes itself.

Healthcare groups managing attributed lives under value-based contracts hit this as full panels and thin margins: certain contracts displace higher-contribution work, and nobody can say which payer mix or panel segment covers the cost per episode. There is no separate industry layer until contribution per provider is visible; the bind is still the contract mix, not additional capacity.

How to tell this is actually your problem

These three together are the signature. One on its own usually points somewhere else.

✓ Every provider is fully scheduled and cash flow is tight
✓ You cannot identify which contracts or panel segments produced contribution last period without a special analysis
✓ Declining additional attributed lives feels impossible even when they are expected to lose money

The move that usually makes it worse. Hiring additional providers to relieve the pressure, which expands capacity for unprofitable contracts and moves the problem one size larger.

Who this is for — and who it is not

It is for you if you run or finance a healthcare provider and everyone is fully occupied and cash is tight. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.

It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

What this looks like when the analysis is actually run

Below is an excerpt from a real run of this analysis on a healthcare provider. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.

The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.

This is one move out of a full analysis. Read a complete report — every page, no email required.

What the engine does with this question

This question routes to Proprietary EFF Methodology, one of 29 engagements the platform runs. For healthcare providers it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.

You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.

Questions people ask about this

How do I know which work to stop taking?

Rank by contribution per unit of your real constraint — machine hour, billable hour, delivery slot, square foot. Not by revenue, and not by gross margin percentage, both of which reliably favour the wrong work when the constraint is capacity.

Will turning away work damage the relationship?

Sometimes, and it is usually cheaper than the alternative. In practice a price that reflects what the work consumes either makes the account profitable or moves it to a competitor, and both outcomes are better than the current one.

Is this a pricing problem or an efficiency problem?

Test it: if every job ran perfectly with zero waste, would the thin ones make money? If the answer is no, it is pricing and selection, and no efficiency programme will reach it.

Is this different in healthcare providers than in other industries?

Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.

What data do I need before this analysis is worth running for a healthcare provider?

Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.

When is Percision the wrong tool?

Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Does Percision replace a lawyer, tax advisor, auditor, or AI implementation team?

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.